BIOTRONIK's First in Man study of the Passeo-18 LUX drug releasing PTA Balloon Catheter
vs. the uncoated Passeo-18 PTA balloon catheter in subjects requiring revascularisation of …

Objective Adenosine diphosphate (ADP) receptor inhibitors such as clopidogrel are known
to be less effective at reducing platelet function for some patients because of a phenomenon …

Objective The optimal timing and modality of surveillance after endovascular intervention for
peripheral arterial disease is controversial, and no randomized trial to assess the value of …

Objective: The aim of the COVER Study is to identify global outcomes and decision making
for vascular procedures during the pandemic. Background Data: During its initial peak, there …

1.1. Purpose The European Society for Vascular Surgery (ESVS) has developed a series of
clinical practice guidelines for clinicians caring for patients with vascular diseases. This is …

Anticoagulant macromolecules have gained widespread use in the clinical treatment of
cardiovascular diseases, blood-contacting or implantable materials, and medical devices …

Objective There is significant practice variation in the use of antithrombotic therapy after
endovascular intervention for lower limb peripheral arterial disease, with differences in …

Objectives: Patients with peripheral arterial occlusive disease (PAOD) are at risk of
worsening limb symptoms, major adverse cardiovascular events and exhibit an impaired life …

Objective Despite the increasing number of fenestrated and branched endovascular aortic
repair (F/B-EVAR) procedures, evidence on post-operative antiplatelet therapy is very …

Background Patients with peripheral arterial occlusive disease (PAOD) are at elevated risk
for cardiovascular events and vascular events affecting the limbs. The goals of …